Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Pierluigi Porcu"'
Publikováno v:
Haematologica
Mogamulizumab, a humanized defucosylated anti-C-C chemokine receptor 4 monoclonal antibody, has been approved in Japan for the treatment of C-C chemokine receptor 4-positive adult T-cell leukemia/lymphoma (ATL). This phase II study evaluated efficacy
Autor:
Jonathan W. Said, George P. Canellos, Eric D. Hsi, Raymond Lai, Amy Chadburn, Andrew D. Zelenetz, David D. Hurd, Myron S. Czuczman, Bruce D. Cheson, Wyndham H. Wilson, Pierluigi Porcu, Dan Jones, Kieron Dunleavy, Jeffrey L. Johnson, Sin-Ho Jung, S. Eric Martin
Publikováno v:
Haematologica. 97:758-765
Background A phase II trial of dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin and rituximab (DA-EPOCH-R) from the National Cancer Institute showed promising activity in untreated diffuse large B-cell lymphoma. The Can